The Impact of Oral Microbiome Dysbiosis on the Aetiology, Pathogenesis, and Development of Oral Cancer
Jasminka Talapko,
No information about this author
Suzana Erić,
No information about this author
Tomislav Meštrović
No information about this author
et al.
Cancers,
Journal Year:
2024,
Volume and Issue:
16(17), P. 2997 - 2997
Published: Aug. 28, 2024
Oral
squamous
cell
carcinoma
(OSCC)
is
the
most
common
head
and
neck
cancer.
Although
oral
cavity
an
easily
accessible
area
for
visual
examination,
OSCC
more
often
detected
at
advanced
stage.
The
global
prevalence
of
around
6%,
with
increasing
trends
posing
a
significant
health
problem
due
to
increase
in
morbidity
mortality.
microbiome
has
been
target
numerous
studies,
findings
highlighting
role
dysbiosis
developing
OSCC.
Dysbiosis
can
significantly
pathobionts
(bacteria,
viruses,
fungi,
parasites)
that
trigger
inflammation
through
their
virulence
pathogenicity
factors.
In
contrast,
chronic
bacterial
contributes
development
Pathobionts
also
have
other
effects,
such
as
impact
on
immune
system,
which
alter
responses
contribute
pro-inflammatory
environment.
Poor
hygiene
carbohydrate-rich
foods
risk
factors
mechanisms
are
not
yet
fully
understood
remain
frequent
research
topic.
For
this
reason,
narrative
review
concentrates
issue
potential
cause
OSCC,
well
underlying
involved.
Language: Английский
Emerging roles of intratumor microbiota in cancer: tumorigenesis and management strategies
Zhuangzhuang Shi,
No information about this author
Zhaoming Li,
No information about this author
Mingzhi Zhang
No information about this author
et al.
Journal of Translational Medicine,
Journal Year:
2024,
Volume and Issue:
22(1)
Published: Sept. 11, 2024
Language: Английский
Revisiting the role of cancer-associated fibroblasts in tumor microenvironment
Xiaolei Lan,
No information about this author
Wenyang Li,
No information about this author
Kai Zhao
No information about this author
et al.
Frontiers in Immunology,
Journal Year:
2025,
Volume and Issue:
16
Published: April 17, 2025
Cancer-associated
fibroblasts
(CAFs)
are
integral
components
of
the
tumor
microenvironment
playing
key
roles
in
progression,
metastasis,
and
therapeutic
resistance.
However,
challenges
persist
understanding
their
heterogeneity,
origin,
functional
diversity.
One
major
obstacle
is
lack
standardized
naming
conventions
for
CAF
subpopulations,
with
current
systems
failing
to
capture
full
complexity.
Additionally,
identification
CAFs
hindered
by
absence
specific
biomarkers,
limiting
precision
diagnostic
strategies.
In
vitro
culture
conditions
often
fail
maintain
vivo
characteristics
CAFs,
which
complicates
study
translation
findings
clinical
practice.
Although
detection
methods,
such
as
antibodies,
mRNA
probes,
single-cell
transcriptomics,
offer
insights
into
biology,
they
standardization
provide
reliable
quantitative
measures.
Furthermore,
dynamic
interactions
between
cells,
immune
cells
within
TME
remain
insufficiently
understood,
role
evasion
therapy
resistance
an
area
ongoing
research.
Understanding
how
influence
drug
response
essential
developing
more
effective
cancer
therapies.
This
review
aims
in-depth
analysis
research,
propose
future
research
directions,
emphasize
need
improved
CAF-targeted
By
addressing
these
gaps,
it
seeks
highlight
potential
targets
overcoming
enhancing
efficacy
treatments.
Language: Английский
The cancer microbiome
Huapeng Li,
No information about this author
Anne A. Leaman,
No information about this author
Qingfei Zheng
No information about this author
et al.
Advances in clinical chemistry,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 1, 2025
Language: Английский
The metabolic dialogue between intratumoural microbes and cancer: implications for immunotherapy
Y. Situ,
No information about this author
Pengpeng Zhang,
No information about this author
Cangang Zhang
No information about this author
et al.
EBioMedicine,
Journal Year:
2025,
Volume and Issue:
115, P. 105708 - 105708
Published: April 22, 2025
Language: Английский
Fusobacterium nucleatum: a novel regulator of antitumor immune checkpoint blockade therapy in colorectal cancer
Mengjie Luo,
No information about this author
Qi Li,
No information about this author
Qingdan Gu
No information about this author
et al.
American Journal of Cancer Research,
Journal Year:
2024,
Volume and Issue:
14(8), P. 3962 - 3975
Published: Jan. 1, 2024
Neoadjuvant
immune
checkpoint
blockade
(ICB)
has
achieved
significant
success
in
treating
various
cancers,
leading
to
improved
therapeutic
responses
and
survival
rates
among
patients.
However,
colorectal
cancer
(CRC),
ICB
yielded
poor
results
tumors
that
are
mismatch
repair
proficient,
microsatellite-stable,
or
have
low
levels
of
microsatellite
instability
(MSI-L),
which
account
for
up
95%
CRC
cases.
The
underlying
mechanisms
behind
the
lack
response
MSI-negative
inhibitors
remain
an
open
conundrum.
Consequently,
there
is
urgent
need
explore
intrinsic
related
biomarkers
enhance
intratumoral
render
tumor
"immune-reactive".
Intestinal
microbes,
such
as
oral
microbiome
member
Fusobacterium
nucleatum
(
Language: Английский
Investigating antibacterial and anti-inflammatory properties of synthetic curcuminoids
Frontiers in Medicine,
Journal Year:
2024,
Volume and Issue:
11
Published: Oct. 29, 2024
The
concept
of
intratumoral
microbiota
is
gaining
attention
in
current
research.
Tumor-associated
can
activate
oncogenic
signaling
pathways
such
as
NF-κB,
thereby
promoting
tumor
development
and
progression.
Numerous
studies
have
demonstrated
that
curcumin
its
analogs
possess
strong
antitumor
effects
by
targeting
the
NF-κB
pathway,
along
with
potent
antibacterial
properties.
In
this
study,
we
tested
activity
two
curcuminoids,
Py-cPen
V-cPen,
against
Gram-negative
bacterial
strains
Language: Английский
Mechanistic and epidemiological evidence on the relationship between microbiota, virome and carcinogenesis
Advances in molecular oncology,
Journal Year:
2024,
Volume and Issue:
11(4), P. 8 - 22
Published: Dec. 9, 2024
Recent
development
of
molecular
and
genetic
technologies
has
demonstrated
at
the
level
co-evolutionary
principles
interaction
between
microbiota,
virome
host
organism,
as
well
role
microorganisms
viruses
both
in
maintaining
physiological
homeostasis
various
diseases,
including
malignant
neoplasms.
The
presented
review
is
devoted
to
analysis
generalization
modern
data
on
inhabiting
human
body,
their
processes
initiation,
promotion
progression
carcinogenesis.
provides
information
known
oncogenic
according
classification
carcinogenic
agents
International
Agency
for
Research
Cancer.
Mechanistic
procarcinogenic
effect
microbiota
are
considered
accordance
with
concept
key
characteristics
a
agent.
Particular
attention
paid
influence
immunity
first
results
immunotherapy
Coley
toxin
soft
tissue
sarcomas
osteosarcomas,
individual
types
formation
immunocompetent
cell
profile
organism.
In
addition,
intratumor
intracellular
respectively,
microenvironment
tumor
cells
cellular
signaling,
solid
tumors
that
have
no
contact
external
environment
also
discussed.
important
terms
holobiota
concept,
showing
interdependent
existence
viruses,
improve
prevention
therapy
Language: Английский
Effect of Gut Dysbiosis on Onset of GI Cancer
Cancers,
Journal Year:
2024,
Volume and Issue:
17(1), P. 90 - 90
Published: Dec. 30, 2024
Dysbiosis
in
the
gut
microbiota
plays
a
significant
role
GI
cancer
development
by
influencing
immune
function
and
disrupting
metabolic
functions.
can
drive
carcinogenesis
through
pathways
like
dysregulation
release
of
carcinogenic
metabolites,
altered
metabolism,
genetic
instability,
pro-inflammatory
signalling,
contributing
to
initiation
progression.
Helicobacter
pylori
infection
genotoxins
released
from
dysbiosis,
lifestyle
dietary
habits
are
other
factors
that
contribute
development.
Emerging
diagnostic
therapeutic
approaches
show
promise
colorectal
treatment,
including
multitarget
faecal
immunochemical
test
(mtFIT),
standard
FIT,
transplantation
(FMT)
combined
with
PD-1
inhibitors.
We
used
search
engine
databases
PubMed,
Scopus,
Web
Science.
This
review
discusses
dysbiosis
onset
explores
strategies
such
as
FMT,
probiotics,
prebiotics
enhance
response
improve
therapy
outcomes.
Language: Английский